Boiron : Unfavourable opinion from the French health authority - Trading of the stock resumes today – Target price lowered to € 35 - Reduce vs Neutral
>Unfavourable opinion from the health authority on maintaining a reimbursement rate of 30%? - The company had demanded on the evening of Thursday 16 May, suspension of its trading given the possible leak of the opinion that the French health authorities is due to hand down on the evaluation of the medical service provided by homeopathy. On this basis, the revision (or not) of the level of coverage and the mandatory reimbursement by health insurance (currently 30%) wou...Boiron manufactures and markets homeopathic medicines. Homeopathic medicines are prepared from vegetable, animal, mineral, or chemical substances, which are diluted. Co. sells three types of products in 59 countries: Non-proprietary homeopathic medicines, OTC family medication specialties, and Other products. There are two large families of homeopathic medicines: Those associated with precise therapeutic indications and dosage, and those that do not mention a therapeutic indication or dosage. Co. supports homeopathy education and training organizations for healthcare professionals. Some of Co.'s brand names include Oscillococcinum®, Stodal®, S?datif PC®, and Coryzalia.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.